Choose Semaglutide If You have established cardiovascular disease (prior heart attack, stroke, stent, peripheral artery disease) You're over 50 with multiple cardiovascular risk factors (hypertension, high LDL, smoking history, family history) You've already lost most of the weight you want to lose and you're switching from short-term weight loss to long-term metabolic protection You want the longest-running real-world safety data on a GLP-1 Choose Tirzepatide If Your primary goal is maximum weight loss in the shortest timeframe You don't have established cardiovascular disease You've plateaued on semaglutide and need stronger appetite suppression You tolerate tirzepatide better (some people get less GI upset on dual agonism) What's Still Available After the FDA Crackdown 503A compounding pharmacies continue to prepare both peptides for documented medical need
Lets talk money, because thats ultimately what determines whether this is worth your time
Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (Nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-B (Nuclear factor B) signals
doi:10.2165/00044011-199510060-00001 42
GLP-1 side effects to monitor for include: Nausea or vomiting Diarrhea or constipation Fatigue Decreased appetite Low blood sugar (hypoglycemia) If any side effects are persistent or concerning to you, contact your prescriber
Bugianesi, E., Moscatiello, S., Ciaravella, M